Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+/calmodulin in PTEN-negative U-87MG human glioblastoma cells

Soon Young Shin, Byeong Hyeok Choi, Je Sang Ko, Se Hyun Kim, Yong Sik Kim, Young Han Lee

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Clozapine (CZP), a dibenzodiazepine derivative with a piperazinyl side chain, is in clinical use as an antipsychotic drug. This study investigated the effect of CZP on the modulation of the PI3K/Akt/GSK-3β pathway in PTEN-negative U-87MG glioblastoma cells. Treatment with CZP rapidly inhibited the basal and EGF-induced phosphorylation of Akt. The inhibition of Akt resulted in the dephosphorylation of GSK-3β and increased GSK-3β kinase activity. A voltage-sensitive Ca2+ channel blocker and calmodulin (CaM) antagonists inhibited Akt phosphorylation, whereas elevation of the intracellular Ca2+ concentration prevented CZP-induced dephosphorylation of Akt and GSK-3β, suggesting that Ca2+/CaM participates in the inhibition of Akt by CZP in U-87MG cells. In addition, similar to LY294002, CZP arrested cell cycle progression at G0/G1 phase, which was accompanied by decreased expression of cyclin D1. The reduction in the cyclin D1 level induced by CZP was abrogated by the inhibition of GSK-3β, the inhibition of proteasome-dependent proteolysis, or an increase in the intracellular Ca2+ concentration. These results suggest that the antipsychotic drug CZP modulates the PI3K/Akt/GSK-3β pathway by counteracting Ca2+/CaM in PTEN-negative U-87MG glioblastoma cells.

Original languageEnglish
Pages (from-to)1876-1886
Number of pages11
JournalCellular Signalling
Volume18
Issue number11
DOIs
Publication statusPublished - 2006 Nov 1

Fingerprint

Clozapine
Calmodulin
Glioblastoma
Glycogen Synthase Kinase 3
Antipsychotic Agents
Cyclin D1
Phosphatidylinositol 3-Kinases
Phosphorylation
Cell Cycle Resting Phase
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
G1 Phase
Proteasome Endopeptidase Complex
Epidermal Growth Factor
Proteolysis
Cell Cycle
Phosphotransferases

Keywords

  • Akt
  • Calmodulin antagonist
  • Cell cycle
  • Clozapine
  • Cyclin D1
  • U-87MG glioblastoma

ASJC Scopus subject areas

  • Cell Biology

Cite this

Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+/calmodulin in PTEN-negative U-87MG human glioblastoma cells. / Shin, Soon Young; Choi, Byeong Hyeok; Ko, Je Sang; Kim, Se Hyun; Kim, Yong Sik; Lee, Young Han.

In: Cellular Signalling, Vol. 18, No. 11, 01.11.2006, p. 1876-1886.

Research output: Contribution to journalArticle

Shin, Soon Young ; Choi, Byeong Hyeok ; Ko, Je Sang ; Kim, Se Hyun ; Kim, Yong Sik ; Lee, Young Han. / Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+/calmodulin in PTEN-negative U-87MG human glioblastoma cells. In: Cellular Signalling. 2006 ; Vol. 18, No. 11. pp. 1876-1886.
@article{10253fb4e2314e01bbd709d2d08bb790,
title = "Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+/calmodulin in PTEN-negative U-87MG human glioblastoma cells",
abstract = "Clozapine (CZP), a dibenzodiazepine derivative with a piperazinyl side chain, is in clinical use as an antipsychotic drug. This study investigated the effect of CZP on the modulation of the PI3K/Akt/GSK-3β pathway in PTEN-negative U-87MG glioblastoma cells. Treatment with CZP rapidly inhibited the basal and EGF-induced phosphorylation of Akt. The inhibition of Akt resulted in the dephosphorylation of GSK-3β and increased GSK-3β kinase activity. A voltage-sensitive Ca2+ channel blocker and calmodulin (CaM) antagonists inhibited Akt phosphorylation, whereas elevation of the intracellular Ca2+ concentration prevented CZP-induced dephosphorylation of Akt and GSK-3β, suggesting that Ca2+/CaM participates in the inhibition of Akt by CZP in U-87MG cells. In addition, similar to LY294002, CZP arrested cell cycle progression at G0/G1 phase, which was accompanied by decreased expression of cyclin D1. The reduction in the cyclin D1 level induced by CZP was abrogated by the inhibition of GSK-3β, the inhibition of proteasome-dependent proteolysis, or an increase in the intracellular Ca2+ concentration. These results suggest that the antipsychotic drug CZP modulates the PI3K/Akt/GSK-3β pathway by counteracting Ca2+/CaM in PTEN-negative U-87MG glioblastoma cells.",
keywords = "Akt, Calmodulin antagonist, Cell cycle, Clozapine, Cyclin D1, U-87MG glioblastoma",
author = "Shin, {Soon Young} and Choi, {Byeong Hyeok} and Ko, {Je Sang} and Kim, {Se Hyun} and Kim, {Yong Sik} and Lee, {Young Han}",
year = "2006",
month = "11",
day = "1",
doi = "10.1016/j.cellsig.2006.02.004",
language = "English",
volume = "18",
pages = "1876--1886",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+/calmodulin in PTEN-negative U-87MG human glioblastoma cells

AU - Shin, Soon Young

AU - Choi, Byeong Hyeok

AU - Ko, Je Sang

AU - Kim, Se Hyun

AU - Kim, Yong Sik

AU - Lee, Young Han

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Clozapine (CZP), a dibenzodiazepine derivative with a piperazinyl side chain, is in clinical use as an antipsychotic drug. This study investigated the effect of CZP on the modulation of the PI3K/Akt/GSK-3β pathway in PTEN-negative U-87MG glioblastoma cells. Treatment with CZP rapidly inhibited the basal and EGF-induced phosphorylation of Akt. The inhibition of Akt resulted in the dephosphorylation of GSK-3β and increased GSK-3β kinase activity. A voltage-sensitive Ca2+ channel blocker and calmodulin (CaM) antagonists inhibited Akt phosphorylation, whereas elevation of the intracellular Ca2+ concentration prevented CZP-induced dephosphorylation of Akt and GSK-3β, suggesting that Ca2+/CaM participates in the inhibition of Akt by CZP in U-87MG cells. In addition, similar to LY294002, CZP arrested cell cycle progression at G0/G1 phase, which was accompanied by decreased expression of cyclin D1. The reduction in the cyclin D1 level induced by CZP was abrogated by the inhibition of GSK-3β, the inhibition of proteasome-dependent proteolysis, or an increase in the intracellular Ca2+ concentration. These results suggest that the antipsychotic drug CZP modulates the PI3K/Akt/GSK-3β pathway by counteracting Ca2+/CaM in PTEN-negative U-87MG glioblastoma cells.

AB - Clozapine (CZP), a dibenzodiazepine derivative with a piperazinyl side chain, is in clinical use as an antipsychotic drug. This study investigated the effect of CZP on the modulation of the PI3K/Akt/GSK-3β pathway in PTEN-negative U-87MG glioblastoma cells. Treatment with CZP rapidly inhibited the basal and EGF-induced phosphorylation of Akt. The inhibition of Akt resulted in the dephosphorylation of GSK-3β and increased GSK-3β kinase activity. A voltage-sensitive Ca2+ channel blocker and calmodulin (CaM) antagonists inhibited Akt phosphorylation, whereas elevation of the intracellular Ca2+ concentration prevented CZP-induced dephosphorylation of Akt and GSK-3β, suggesting that Ca2+/CaM participates in the inhibition of Akt by CZP in U-87MG cells. In addition, similar to LY294002, CZP arrested cell cycle progression at G0/G1 phase, which was accompanied by decreased expression of cyclin D1. The reduction in the cyclin D1 level induced by CZP was abrogated by the inhibition of GSK-3β, the inhibition of proteasome-dependent proteolysis, or an increase in the intracellular Ca2+ concentration. These results suggest that the antipsychotic drug CZP modulates the PI3K/Akt/GSK-3β pathway by counteracting Ca2+/CaM in PTEN-negative U-87MG glioblastoma cells.

KW - Akt

KW - Calmodulin antagonist

KW - Cell cycle

KW - Clozapine

KW - Cyclin D1

KW - U-87MG glioblastoma

UR - http://www.scopus.com/inward/record.url?scp=33749253862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749253862&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2006.02.004

DO - 10.1016/j.cellsig.2006.02.004

M3 - Article

C2 - 16542821

AN - SCOPUS:33749253862

VL - 18

SP - 1876

EP - 1886

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 11

ER -